To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
Iannone, F., La Montagna, G., Bagnato, G., Gremese, E., Giardina, A., Lapadula, G., Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial, <<THE JOURNAL OF RHEUMATOLOGY>>, 2014; 41 (2): 286-292. [doi:10.3899/jrheum.130658] [http://hdl.handle.net/10807/64961]
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial
Gremese, Elisa;
2014
Abstract
To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
